Last reviewed · How we verify
Delayed enteral nutrition
Delayed enteral nutrition is a Small molecule drug developed by Nanjing University School of Medicine. It is currently FDA-approved for Post-operative nutritional management, Critical illness nutritional support, Trauma recovery.
Delayed enteral nutrition is a nutritional intervention strategy that postpones the initiation of feeding via the gastrointestinal tract following acute illness or injury.
Delayed enteral nutrition is a nutritional intervention strategy that postpones the initiation of feeding via the gastrointestinal tract following acute illness or injury. Used for Post-operative nutritional management, Critical illness nutritional support, Trauma recovery.
At a glance
| Generic name | Delayed enteral nutrition |
|---|---|
| Sponsor | Nanjing University School of Medicine |
| Modality | Small molecule |
| Therapeutic area | Critical Care / Nutritional Support |
| Phase | FDA-approved |
Mechanism of action
This approach involves withholding or delaying oral or tube feeding for a defined period after acute events (such as surgery, trauma, or critical illness) to allow the gastrointestinal tract to stabilize and reduce complications. The rationale is to minimize feeding-related complications while maintaining metabolic support through alternative routes, though current evidence suggests early enteral nutrition may be preferable in many clinical contexts.
Approved indications
- Post-operative nutritional management
- Critical illness nutritional support
- Trauma recovery
Common side effects
- Malnutrition
- Delayed recovery
- Increased infection risk
Key clinical trials
- Assessing Timing of Enteral Feeding Support in Esophageal Cancer Patients on Muscle functTion and Survival (NA)
- Early Human Milk Fortification After Early, Exclusive, Enteral Nutrition in Very Preterm Infants (NA)
- Late-onset Sepsis and Development
- Oral Enteral Nutrition in Delayed Onset Radiotherapy-related Swallowing Disorder in Nasopharyngeal Carcinoma (NA)
- Intermittent Oral-esophageal Tube Feeding in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma (NA)
- Intermittent Oral-esophageal Tube in Delayed Dysphagia After Radiotherapy for Nasopharyngeal Carcinoma (NA)
- Early Versus Delayed Enteral Nutrition in Critically Ill Adults With COVID-19
- Genotype-phenotype Correlations in Children and Adults With CTNNB1 Mutation
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Delayed enteral nutrition CI brief — competitive landscape report
- Delayed enteral nutrition updates RSS · CI watch RSS
- Nanjing University School of Medicine portfolio CI
Frequently asked questions about Delayed enteral nutrition
What is Delayed enteral nutrition?
How does Delayed enteral nutrition work?
What is Delayed enteral nutrition used for?
Who makes Delayed enteral nutrition?
What development phase is Delayed enteral nutrition in?
What are the side effects of Delayed enteral nutrition?
Related
- Manufacturer: Nanjing University School of Medicine — full pipeline
- Therapeutic area: All drugs in Critical Care / Nutritional Support
- Indication: Drugs for Post-operative nutritional management
- Indication: Drugs for Critical illness nutritional support
- Indication: Drugs for Trauma recovery
- Compare: Delayed enteral nutrition vs similar drugs
- Pricing: Delayed enteral nutrition cost, discount & access